Literature DB >> 23863903

ERAAP and tapasin independently edit the amino and carboxyl termini of MHC class I peptides.

Takayuki Kanaseki1, Kristin Camfield Lind, Hernando Escobar, Niranjana Nagarajan, Eduardo Reyes-Vargas, Brant Rudd, Alan L Rockwood, Luc Van Kaer, Noriyuki Sato, Julio C Delgado, Nilabh Shastri.   

Abstract

Effective CD8(+) T cell responses depend on presentation of a stable peptide repertoire by MHC class I (MHC I) molecules on the cell surface. The overall quality of peptide-MHC I complexes (pMHC I) is determined by poorly understood mechanisms that generate and load peptides with appropriate consensus motifs onto MHC I. In this article, we show that both tapasin (Tpn), a key component of the peptide loading complex, and the endoplasmic reticulum aminopeptidase associated with Ag processing (ERAAP) are quintessential editors of distinct structural features of the peptide repertoire. We carried out reciprocal immunization of wild-type mice with cells from Tpn- or ERAAP-deficient mice. Specificity analysis of T cell responses showed that absence of Tpn or ERAAP independently altered the peptide repertoire by causing loss as well as gain of new pMHC I. Changes in amino acid sequences of MHC-bound peptides revealed that ERAAP and Tpn, respectively, defined the characteristic amino and carboxy termini of canonical MHC I peptides. Thus, the optimal pMHC I repertoire is produced by two distinct peptide editing steps in the endoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23863903      PMCID: PMC3735839          DOI: 10.4049/jimmunol.1301043

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

Review 1.  Degradation of cell proteins and the generation of MHC class I-presented peptides.

Authors:  K L Rock; A L Goldberg
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

2.  Productive association between MHC class I and tapasin requires the tapasin transmembrane/cytosolic region and the tapasin C-terminal Ig-like domain.

Authors:  Laura C Simone; Corey J Georgesen; Peter D Simone; Xiaojian Wang; Joyce C Solheim
Journal:  Mol Immunol       Date:  2011-12-12       Impact factor: 4.407

3.  Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses.

Authors:  B Pérarnau; M F Saron; B Reina San Martin; N Bervas; H Ong; M J Soloski; A G Smith; J M Ure; J E Gairin; F A Lemonnier
Journal:  Eur J Immunol       Date:  1999-04       Impact factor: 5.532

Review 4.  Antigen processing and presentation.

Authors:  Peter Cresswell
Journal:  Immunol Rev       Date:  2005-10       Impact factor: 12.988

5.  The N-terminal region of tapasin is required to stabilize the MHC class I loading complex.

Authors:  N Bangia; P J Lehner; E A Hughes; M Surman; P Cresswell
Journal:  Eur J Immunol       Date:  1999-06       Impact factor: 5.532

6.  Distinct functions for the glycans of tapasin and heavy chains in the assembly of MHC class I molecules.

Authors:  Syed Monem Rizvi; Natasha Del Cid; Lonnie Lybarger; Malini Raghavan
Journal:  J Immunol       Date:  2011-01-24       Impact factor: 5.422

7.  Natural killer cells efficiently reject lymphoma silenced for the endoplasmic reticulum aminopeptidase associated with antigen processing.

Authors:  Loredana Cifaldi; Elisa Lo Monaco; Matteo Forloni; Ezio Giorda; Silvia Lorenzi; Stefania Petrini; Elisa Tremante; Daniela Pende; Franco Locatelli; Patrizio Giacomini; Doriana Fruci
Journal:  Cancer Res       Date:  2011-01-20       Impact factor: 12.701

8.  Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1.

Authors:  Sungchul Kim; Sanghyun Lee; Jinwook Shin; Youngkyun Kim; Irini Evnouchidou; Donghyun Kim; Young-Kook Kim; Young-Eui Kim; Jin-Hyun Ahn; Stanley R Riddell; Efstratios Stratikos; V Narry Kim; Kwangseog Ahn
Journal:  Nat Immunol       Date:  2011-09-04       Impact factor: 25.606

9.  Evidence for successive peptide binding and quality control stages during MHC class I assembly.

Authors:  J W Lewis; T Elliott
Journal:  Curr Biol       Date:  1998-06-04       Impact factor: 10.834

10.  Nonclassical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulum.

Authors:  Niranjana A Nagarajan; Federico Gonzalez; Nilabh Shastri
Journal:  Nat Immunol       Date:  2012-04-22       Impact factor: 25.606

View more
  15 in total

1.  The first step of peptide selection in antigen presentation by MHC class I molecules.

Authors:  Malgorzata A Garstka; Alexander Fish; Patrick H N Celie; Robbie P Joosten; George M C Janssen; Ilana Berlin; Rieuwert Hoppes; Magda Stadnik; Lennert Janssen; Huib Ovaa; Peter A van Veelen; Anastassis Perrakis; Jacques Neefjes
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

2.  Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition.

Authors:  Yosuke Shionoya; Takayuki Kanaseki; Sho Miyamoto; Serina Tokita; Ayumi Hongo; Yasuhiro Kikuchi; Vitaly Kochin; Kazue Watanabe; Ryota Horibe; Hiroshi Saijo; Tomohide Tsukahara; Yoshihiko Hirohashi; Hiroki Takahashi; Noriyuki Sato; Toshihiko Torigoe
Journal:  Oncoimmunology       Date:  2017-01-03       Impact factor: 8.110

3.  Human Leukocyte Antigen (HLA) Peptides Derived from Tumor Antigens Induced by Inhibition of DNA Methylation for Development of Drug-facilitated Immunotherapy.

Authors:  Bracha Shraibman; Dganit Melamed Kadosh; Eilon Barnea; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2016-07-13       Impact factor: 5.911

4.  Interaction of TAPBPR, a tapasin homolog, with MHC-I molecules promotes peptide editing.

Authors:  Giora I Morozov; Huaying Zhao; Michael G Mage; Lisa F Boyd; Jiansheng Jiang; Michael A Dolan; Ramesh Venna; Michael A Norcross; Curtis P McMurtrey; William Hildebrand; Peter Schuck; Kannan Natarajan; David H Margulies
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-11       Impact factor: 11.205

5.  Distinct assembly profiles of HLA-B molecules.

Authors:  Syed Monem Rizvi; Nasir Salam; Jie Geng; Ying Qi; Jay H Bream; Priya Duggal; Shehnaz K Hussain; Jeremy Martinson; Steven M Wolinsky; Mary Carrington; Malini Raghavan
Journal:  J Immunol       Date:  2014-04-30       Impact factor: 5.422

Review 6.  Monitoring peptide processing for MHC class I molecules in the endoplasmic reticulum.

Authors:  Nilabh Shastri; Niranjana Nagarajan; Kristin C Lind; Takayuki Kanaseki
Journal:  Curr Opin Immunol       Date:  2013-12-11       Impact factor: 7.486

7.  Molecular mechanism of peptide editing in the tapasin-MHC I complex.

Authors:  Olivier Fisette; Sebastian Wingbermühle; Robert Tampé; Lars V Schäfer
Journal:  Sci Rep       Date:  2016-01-12       Impact factor: 4.379

8.  TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst.

Authors:  Clemens Hermann; Andy van Hateren; Nico Trautwein; Andreas Neerincx; Patrick J Duriez; Stefan Stevanović; John Trowsdale; Janet E Deane; Tim Elliott; Louise H Boyle
Journal:  Elife       Date:  2015-10-06       Impact factor: 8.140

9.  Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa.

Authors:  Angelique Hölzemer; Christina F Thobakgale; Camilo A Jimenez Cruz; Wilfredo F Garcia-Beltran; Jonathan M Carlson; Nienke H van Teijlingen; Jaclyn K Mann; Manjeetha Jaggernath; Seung-gu Kang; Christian Körner; Amy W Chung; Jamie L Schafer; David T Evans; Galit Alter; Bruce D Walker; Philip J Goulder; Mary Carrington; Pia Hartmann; Thomas Pertel; Ruhong Zhou; Thumbi Ndung'u; Marcus Altfeld
Journal:  PLoS Med       Date:  2015-11-17       Impact factor: 11.069

10.  ERAP1-ERAP2 dimers trim MHC I-bound precursor peptides; implications for understanding peptide editing.

Authors:  Hanna Chen; Lenong Li; Mirjana Weimershaus; Irini Evnouchidou; Peter van Endert; Marlene Bouvier
Journal:  Sci Rep       Date:  2016-08-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.